首页> 外国专利> BUB3 AURKB PTTG1 RAD21 DIAGNOSTIC METHODS FOR PROGNOSIS OF NON-SMALL-CELL LUNG CANCER USING BUB3 AURKB PTTG1 AND RAD21 SNPs

BUB3 AURKB PTTG1 RAD21 DIAGNOSTIC METHODS FOR PROGNOSIS OF NON-SMALL-CELL LUNG CANCER USING BUB3 AURKB PTTG1 AND RAD21 SNPs

机译:使用BUB3 AURKB PTTG1和RAD21 SNPs诊断非小细胞肺癌的BUB3 AURKB PTTG1 RAD21诊断方法

摘要

The present invention relates to single nucleotide polymorphisms of the BUB3, AURKB, PTTG1 and RAD21 genes for prediction of the prognosis of non-small cell lung cancer (NSCLC). More specifically, the BUB3 gene uses SNP of rs7897156, Methods for diagnosing and predicting the prognosis of early stage non-small cell lung cancer using the rs1059476 SNP, the rs1059476 SNP, the rs1895320 SNP, and the RAD21 gene using rs1374297 SNP And its use. The prognosis of non-small cell lung cancer survival prognosis according to the present invention can be evaluated by easily evaluating the prognosis of patients with non-small cell lung cancer and by targeting means and treatment for selection and evaluation of treatment methods, .
机译:本发明涉及BUB3,AURKB,PTTG1和RAD21基因的单核苷酸多态性,用于预测非小细胞肺癌(NSCLC)的预后。更具体地说,BUB3基因使用rs7897156的SNP,使用rs1059476 SNP,rs1059476 SNP,rs1895320 SNP和使用rs1374297 SNP的RAD21基因诊断和预测早期非小细胞肺癌预后的方法及其用途。可以通过容易地评估非小细胞肺癌患者的预后并通过靶向手段和治疗方法来选择和评估治疗方法来评估根据本发明的非小细胞肺癌生存预后。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号